Nuvation Bio
NUVB
NUVB
105 hedge funds and large institutions have $1.32B invested in Nuvation Bio in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.87% more ownership
Funds ownership: 69.47% → 71.35% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
12% less capital invested
Capital invested by funds: $1.5B → $1.32B (-$184M)
Holders
105
Holding in Top 10
4
Calls
$371K
Puts
$124K
Top Buyers
| 1 | +$45.9M | |
| 2 | +$11.3M | |
| 3 | +$6.36M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$5.69M |
| 5 |
JPMorgan Chase & Co
New York
|
+$5.27M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$7.4M | |
| 3 | -$6.63M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.46M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.95M |